Rhenman & Partners Asset Management AB - SALIX PHARMACEUTICALS INC ownership

SALIX PHARMACEUTICALS INC's ticker is SLXP and the CUSIP is 795435106. A total of 319 filers reported holding SALIX PHARMACEUTICALS INC in Q1 2015. The put-call ratio across all filers is 0.43 and the average weighting 1.3%.

Quarter-by-quarter ownership
Rhenman & Partners Asset Management AB ownership history of SALIX PHARMACEUTICALS INC
ValueSharesWeighting
Q4 2014$4,368,000
-48.2%
38,000
-29.6%
1.27%
-48.7%
Q3 2014$8,437,000
+57.3%
54,000
+24.2%
2.47%
+55.2%
Q2 2014$5,365,000
-3.7%
43,493
-19.1%
1.59%
-4.8%
Q1 2014$5,573,000
+12.7%
53,788
-2.2%
1.67%
-13.5%
Q4 2013$4,947,00055,0001.94%
Other shareholders
SALIX PHARMACEUTICALS INC shareholders Q1 2015
NameSharesValueWeighting ↓
MONETARY MANAGEMENT GROUP INC 300$52,0000.02%
View complete list of SALIX PHARMACEUTICALS INC shareholders